LEADER 01776oam  2200529   450 
001 9910712079503321
005 20200317141021.0
035   $a(CKB)5470000002489304
035   $a(OCoLC)1090765245
035   $a(EXLCZ)995470000002489304
100   $a20190327d2019      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPresidential Transition Enhancement Act of 2019 $ereport of the Committee on Homeland Security and Governmental Affairs, United States Senate, to accompany S. 394, to amend the Presidential Transition Act of 1963 to improve the orderly transfer of the executive power during presidential transitions
210  1$aWashington :$cU.S. Government Publishing Office,$d2019.
215   $a1 online resource (ii, 12 pages)
225 1 $aReport / 116th Congress, 1st session, Senate ;$v116-13
300   $a"March 25, 2019."
320   $aIncludes bibliographical references.
517   $aPresidential Transition Enhancement Act of 2019 
606   $aPresidents$zUnited States$xTransition periods$xPlanning
607   $aUnited States$2fast
608   $aLegislative materials.$2fast
608   $aRules.$2fast
608   $aLegislative materials.$2lcgft
615  0$aPresidents$xTransition periods$xPlanning.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bTLK
801  2$bOCLCO
801  2$bCOO
801  2$bOCLCO
801  2$bUPM
801  2$bOCLCO
801  2$bTXR
801  2$bOCLCF
801  2$bOCLCO
801  2$bDWP
801  2$bGPO
906   $aBOOK
912   $a9910712079503321
996   $aPresidential Transition Enhancement Act of 2019$93338679
997   $aUNINA

LEADER 01989nam  2200553 a 450 
001 9910791770403321
005 20200520144314.0
010   $a1-61761-033-X
035   $a(CKB)2560000000069708
035   $a(EBL)3020832
035   $a(SSID)ssj0000469914
035   $a(PQKBManifestationID)11307598
035   $a(PQKBTitleCode)TC0000469914
035   $a(PQKBWorkID)10531711
035   $a(PQKB)11462117
035   $a(MiAaPQ)EBC3020832
035   $a(Au-PeEL)EBL3020832
035   $a(CaPaEBR)ebr10680970
035   $a(OCoLC)923664535
035   $a(EXLCZ)992560000000069708
100   $a20100617d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aHepatitis C infection in dialysis$b[electronic resource] /$fMagid A. Fahim and David W. Johnson
210   $aNew York $cNova Biomedical Books/Novinka$dc2010
215   $a1 online resource (58 p.)
225 1 $aNephrology research and clinical developments
300   $aDescription based upon print version of record.
311   $a1-61728-851-9 
320   $aIncludes bibliographical references (p. [35]-41) and index.
327   $aEpidemiology -- Risk factors for HCV acquisition in haemodialysis patients -- Prevention of HCV transmission in haemodialysis units -- Diagnosis, screening, and evaluation -- Hepatic pathology and complications -- Treatment and monitoring -- Outcomes.
410  0$aNephrology research and clinical developments series.
606   $aHepatitis C
606   $aHemodialysis$xComplications
615  0$aHepatitis C.
615  0$aHemodialysis$xComplications.
676   $a616.3/623
700   $aFahim$b Magid A$01537248
701   $aJohnson$b David W$g(David Wayne),$f1964-$01537249
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910791770403321
996   $aHepatitis C infection in dialysis$93786440
997   $aUNINA

LEADER 00899cam0-2200313---450 
001 990004945760403321
005 20240215135703.0
035   $a000494576
035   $aFED01000494576
035   $a(Aleph)000494576FED01
100   $a19990604d1967----km-y0itay50------ba
101 0 $aeng
102   $aGB
105   $ay-------001yy
200 1 $aLanguages in contact$efindings and problems$fby Uriel Weinreich$gwith a preface by André Martinet
205   $a5nd ed.
210   $aLondon$cMouton$d1967
215   $aXII, 149 p.$d25 cm
610 0 $aBilinguismo
676   $a404.2
700  1$aWeinreich,$bUriel$f<1926-1967>$0319442
702  1$aMartinet,$bAndré
801  0$aIT$bUNINA$c20070420$gRICA$2UNIMARC
901   $aBK
912   $a990004945760403321
952   $a409.2 WEIN 01$bIst.glott.1237$fFLFBC
959   $aFLFBC
996   $aLanguages in contact$939738
997   $aUNINA